Bioactive tea compounds show potential anti-SARS-CoV-2 activity

NewsGuard 100/100 Score

Scientists from the Kyoto Prefectural University of Medicine and the Central Research Institute, Japan, have revealed that certain bioactive compounds found in green, black, and oolong tea possess remarkable antiviral activities against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19). The study is currently available on the bioRxiv* preprint server.

Green Tea

Green Tea. Image Credit: taa22/

As of December 7, 2020, more than 66 million confirmed cases of COVID-19, including 1.5 million deaths, have been reported to the World Health Organization (WHO). Although the majority of COVID-19 patients remain asymptomatic or mildly symptomatic, the risk of developing a severe illness is still high among susceptible individuals.

Currently, many repurposed antiviral drugs along with corticosteroids are being routinely used to treat severe COVID-19 patients, and many of these drugs are showing promising outcomes.

Given the high safety and tolerability profiles of several plant compounds, many studies have been conducted to evaluate the effectiveness of these in treating SARS-CoV-2. Epigallocatechin gallate (EGCG) is one such polyphenolic compound found in green tea that has shown therapeutic benefits in cardiovascular, metabolic, neurological, and infectious diseases and cancer.

Oxidation of EGCG gives rise to several multimers, such as theasinensin A (TSA) and theaflavin 3, 3’-di-gallate (TFDG), which are different types of polyphenolic compounds found in black tea and oolong tea.

Current study design

In the current study, scientists aimed to investigate the effects of various tea compounds in eliminating SARS-CoV-2. Specifically, they pretreated SARS-CoV-2 with various tea extracts and purified tea catechins, catechin derivatives, and theaflavins to check the antiviral efficacy of these compounds. They used VeroE6 cells overexpressing TMPRSS2 as an in vitro model to conduct the experiments.

Important observations

The scientists observed that the treatment of SARS-CoV-2 with black, green, and oolong tea extracts caused a significant reduction in viral titer, which eventually reduced below the detectable range. Among various tea extracts, the black tea extract showed the highest effect. Moreover, the tea extracts strongly inactivated SARS-CoV-2 and prevented it from damaging VeroE6 cells.

Bioactive tea compounds

The scientists tested various tea catechins and theaflavins to identify potential antiviral compounds. The study findings revealed that EGCG, TSA, and TFDG strongly inactivated the virus, with TSA and TFDG exhibiting comparatively higher antiviral activity than EGCG. Specifically, TSA and TFDG at 500 µM and 100 µM doses, respectively, reduced the viral titer below the detectable limit.     

In addition, the scientists observed that SARS-CoV-2 pretreated with TSA or TFDG could not reduce the viability of VeroE6 cells. To get a comparable level of protection, a higher concentration of EGCG was required.

In a separate set of experiments, they pretreated VeroE6 cells with EGCG, TSA, and TFDG and subsequently infected the cells with untreated SARS-CoV-2. Interestingly, they observed that the risk of getting infection was equally high for both pretreated and untreated cells. These findings indicate that tested tea compounds are effective in directly inactivating the virus, but may not act directly on the cells to prevent viral entry.

For further clarification, they assessed the viral RNA load in cells that were infected with EGCG-, TSA-, or TFDG-pretreated virus. The findings revealed that the tea compounds, especially TSA and TFDG, significantly reduced the replication and release of SARS-CoV-2.

Mode of action

To investigate the mode of action of active tea compounds, they checked the interaction between recombinant angiotensin-converting enzyme 2 (ACE2) and receptor-binding domain (RBD) of the viral spike protein in presence of EGCG, TSA, and TFDG. The findings revealed that TSA and TFDG strongly and EGCG moderately inhibited the interaction.

TSA and TFDG interfered with the interaction between ACE2 and RBD

TSA and TFDG interfered with the interaction between ACE2 and RBD. Image Credit:

Study significance

The current study identifies potential bioactive tea compounds with antiviral activity against SARS-CoV-2. The anti-cancer, anti-inflammatory, antioxidant, and anti-microbial efficacies of these compounds has been well documented in the literature. Although consumption of a few cups of tea is not sufficient to achieve the effective antiviral dose of these compounds in the blood, the scientists believe that oral intake of EGCG, TSA, and TFDG can ensure protection against SARS-CoV-2 in the oral cavity and gastrointestinal tract.

Journal reference:
Dr. Sanchari Sinha Dutta

Written by

Dr. Sanchari Sinha Dutta

Dr. Sanchari Sinha Dutta is a science communicator who believes in spreading the power of science in every corner of the world. She has a Bachelor of Science (B.Sc.) degree and a Master's of Science (M.Sc.) in biology and human physiology. Following her Master's degree, Sanchari went on to study a Ph.D. in human physiology. She has authored more than 10 original research articles, all of which have been published in world renowned international journals.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dutta, Sanchari Sinha Dutta. (2020, December 08). Bioactive tea compounds show potential anti-SARS-CoV-2 activity. News-Medical. Retrieved on April 25, 2024 from

  • MLA

    Dutta, Sanchari Sinha Dutta. "Bioactive tea compounds show potential anti-SARS-CoV-2 activity". News-Medical. 25 April 2024. <>.

  • Chicago

    Dutta, Sanchari Sinha Dutta. "Bioactive tea compounds show potential anti-SARS-CoV-2 activity". News-Medical. (accessed April 25, 2024).

  • Harvard

    Dutta, Sanchari Sinha Dutta. 2020. Bioactive tea compounds show potential anti-SARS-CoV-2 activity. News-Medical, viewed 25 April 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New vaccine promises broad protection against SARS-CoV-2 and other sarbecoviruses